Key facts
- This page summarizes John C.k. Milligan IV's Form 4 filing for TherapeuticsMD, Inc. (TXMD).
- 3 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 12 May 2021, 20:38.
John C.k. Milligan IV - 10 May 2021 Form 4 Insider Report for TherapeuticsMD, Inc. (TXMD)
- Reporting relationship
- Secretary/CEO of subsidiary
- Issuer ticker
- TXMD
- Reported as of
- 10 May 2021
- Net transaction value
- -$46,022
- Reporting owner signature
- /s/ John C.K. Milligan, IV
Source evidence
Original filing metadata and source links for verification.
3 source fields
Reporting owner
1 detail
Key filing fact
John C.k. Milligan IV filed Form 4 for TherapeuticsMD, Inc. (TXMD) on 12 May 2021.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: -$46,022.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
TXMD
transaction
Common Stock
Options Exercise
- Transaction value
- Shares
- +103,500
- Change %
- +6.1%
- Price
- Shares after
- 1,796,955
- Date
- 10 May 2021
- Ownership
- Direct
- Footnotes
- F1
TXMD
transaction
Common Stock
Sale
- Transaction value
- $46,022
- Shares
- -44,252
- Change %
- -2.5%
- Price
- $1.04
- Shares after
- 1,752,703
- Date
- 11 May 2021
- Ownership
- Direct
- Footnotes
- F2
TXMD
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 3,582,373
- Date
- 10 May 2021
- Ownership
- See Footnote
- Footnotes
- F3
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
TXMD
transaction
Derivative
Restricted Stock Units
Options Exercise
- Transaction value
- $0
- Shares
- -103,500
- Change %
- -33%
- Price
- $0.000000
- Shares after
- 207,000
- Date
- 10 May 2021
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 103,500
- Exercise price
- $0.000000
- Footnotes
- F1, F4, F5
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 5 footnotes
Footnote F1
On May 10, 2021, the reporting person received 103,500 shares of issuer common stock in settlement of restricted stock units (RSUs), which vested on March 30, 2021.
Footnote F2
The reported securities represent shares of issuer common stock sold upon settlement to satisfy tax obligations.
Footnote F3
Shares are owned by John C.K. Milligan Revocable Trust U/A 08/10/2009, as amended.
Footnote F4
Each RSU represents a contingent right to receive one share of issuer common stock upon settlement.
Footnote F5
The RSUs vest in three equal installments annually beginning March 30, 2021, becoming fully vested on March 30, 2023.